AU2002228413B8 - Process for producing (3R,5S)-(E)-7-[2-Cyclopropyl-4-(4-Fluorophenyl)-Quinolin-3-yl]-3,5-Dihydroxyhept -6-enic acid esters - Google Patents

Process for producing (3R,5S)-(E)-7-[2-Cyclopropyl-4-(4-Fluorophenyl)-Quinolin-3-yl]-3,5-Dihydroxyhept -6-enic acid esters Download PDF

Info

Publication number
AU2002228413B8
AU2002228413B8 AU2002228413A AU2002228413A AU2002228413B8 AU 2002228413 B8 AU2002228413 B8 AU 2002228413B8 AU 2002228413 A AU2002228413 A AU 2002228413A AU 2002228413 A AU2002228413 A AU 2002228413A AU 2002228413 B8 AU2002228413 B8 AU 2002228413B8
Authority
AU
Australia
Prior art keywords
formula
group
compound
genus
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002228413A
Other languages
English (en)
Other versions
AU2002228413A1 (en
AU2002228413B2 (en
Inventor
Mari Hara
Akemi Hosokawa
Yuzo Kasuga
Manabu Katsurada
Youichi Matsumoto
Yuki Takuma
Naoyuki Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Nissan Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2001331480A external-priority patent/JP2003137870A/ja
Application filed by Mitsubishi Chemical Corp, Nissan Chemical Corp filed Critical Mitsubishi Chemical Corp
Publication of AU2002228413A1 publication Critical patent/AU2002228413A1/en
Publication of AU2002228413B2 publication Critical patent/AU2002228413B2/en
Application granted granted Critical
Publication of AU2002228413B8 publication Critical patent/AU2002228413B8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • C12P17/12Nitrogen as only ring hetero atom containing a six-membered hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2002228413A 2001-02-02 2002-02-01 Process for producing (3R,5S)-(E)-7-[2-Cyclopropyl-4-(4-Fluorophenyl)-Quinolin-3-yl]-3,5-Dihydroxyhept -6-enic acid esters Ceased AU2002228413B8 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001-26316 2001-02-02
JP2001026316 2001-02-02
JP2001-331480 2001-10-29
JP2001331480A JP2003137870A (ja) 2001-10-29 2001-10-29 3,5−ジオキソ−6−ヘプテン酸誘導体類の製造方法及びその中間体
PCT/JP2002/000835 WO2002063028A1 (fr) 2001-02-02 2002-02-01 Procede de production d'esters d'acide (3r,5s)-(e)-7-[2-cyclopropyl-4-(4-fluorophenyl)-quinolin-3-yl]-3,5-dihydroxyhept-6-enique

Publications (3)

Publication Number Publication Date
AU2002228413A1 AU2002228413A1 (en) 2002-08-19
AU2002228413B2 AU2002228413B2 (en) 2007-02-22
AU2002228413B8 true AU2002228413B8 (en) 2007-03-22

Family

ID=26608822

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002228413A Ceased AU2002228413B8 (en) 2001-02-02 2002-02-01 Process for producing (3R,5S)-(E)-7-[2-Cyclopropyl-4-(4-Fluorophenyl)-Quinolin-3-yl]-3,5-Dihydroxyhept -6-enic acid esters

Country Status (8)

Country Link
US (1) US6965031B2 (enExample)
EP (1) EP1365029A4 (enExample)
KR (1) KR100883874B1 (enExample)
CN (1) CN1329520C (enExample)
AU (1) AU2002228413B8 (enExample)
CA (1) CA2437312C (enExample)
TW (1) TWI322829B (enExample)
WO (1) WO2002063028A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI322829B (enExample) * 2001-02-02 2010-04-01 Mitsubishi Chem Corp
UA76984C2 (en) * 2001-04-05 2006-10-16 Nissan Chemical Ind Ltd A method for preparing a 7-qunolinyl-3,5-dihydroxyhept-6-enoate
ATE426594T1 (de) * 2002-01-31 2009-04-15 Novartis Pharma Gmbh Verfahren zur herstellung von inhibitoren der hmg-coa-reduktase
EP1491633B1 (en) * 2002-03-19 2008-08-27 Mitsubishi Chemical Corporation Novel carbonyl reductase, gene encoding it and process for producing optically active alcohols using the same
ITMI20100753A1 (it) * 2010-04-30 2011-10-31 Dipharma Francis Srl Procedimento per la preparazione di statine
EP2383260A3 (en) * 2010-04-30 2011-12-28 Dipharma Francis S.r.l. Process for the preparation of statins
CN103848784B (zh) * 2012-12-05 2016-12-21 安徽省庆云医药化工有限公司 匹伐他汀酯的晶型及其制备方法
JP6150703B2 (ja) * 2013-10-08 2017-06-21 ダイト株式会社 ピタバスタチンカルシウム塩の分解抑制方法
CN106029895B (zh) * 2014-02-06 2021-07-16 株式会社Api 瑞舒伐他汀钙及其中间体的生产方法
JP6649263B2 (ja) * 2014-10-10 2020-02-19 株式会社エーピーアイ コーポレーション スタチン系化合物の精製方法
CN107949556B (zh) * 2015-08-05 2021-12-07 株式会社Api 生产匹伐他汀钙的方法
CN105481838A (zh) * 2015-11-18 2016-04-13 北京万全德众医药生物技术有限公司 一种制备匹伐他汀内酯杂质的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6965031B2 (en) * 2001-02-02 2005-11-15 Mitsubishi Chemical Corporation Process for producing (3R,5S)-(E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-quinolin- 3-yl]-3,5-dihydroxyhept-6-enic acid esters

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1336714C (en) * 1987-08-20 1995-08-15 Yoshihiro Fujikawa Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
JP3149265B2 (ja) 1992-05-12 2001-03-26 鐘淵化学工業株式会社 光学活性な3,5−ジヒドロキシ脂肪酸エステル誘導体の製造法
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
JP3554036B2 (ja) * 1994-09-06 2004-08-11 宇部興産株式会社 光学活性な7−置換キノリル−3,5−ジヒドロキシ−ヘプト−6−エン酸エステル誘導体の製造方法
JP3481325B2 (ja) * 1994-09-06 2003-12-22 宇部興産株式会社 光学活性な3−オキシ−5−オキソ−6−ヘプテン酸誘導体の製法
GB9512837D0 (en) 1995-06-23 1995-08-23 Zeneca Ltd reduction of ketone groups

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6965031B2 (en) * 2001-02-02 2005-11-15 Mitsubishi Chemical Corporation Process for producing (3R,5S)-(E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-quinolin- 3-yl]-3,5-dihydroxyhept-6-enic acid esters

Also Published As

Publication number Publication date
CN1329520C (zh) 2007-08-01
EP1365029A4 (en) 2009-07-29
EP1365029A1 (en) 2003-11-26
AU2002228413A1 (en) 2002-08-19
US6965031B2 (en) 2005-11-15
AU2002228413B2 (en) 2007-02-22
WO2002063028A1 (fr) 2002-08-15
CA2437312A1 (en) 2002-08-15
TWI322829B (enExample) 2010-04-01
CA2437312C (en) 2010-03-23
KR100883874B1 (ko) 2009-02-17
US20040030139A1 (en) 2004-02-12
KR20030072618A (ko) 2003-09-15
CN1633502A (zh) 2005-06-29

Similar Documents

Publication Publication Date Title
AU2002228413B2 (en) Process for producing (3R,5S)-(E)-7-[2-Cyclopropyl-4-(4-Fluorophenyl)-Quinolin-3-yl]-3,5-Dihydroxyhept -6-enic acid esters
Patel et al. Enantioselective microbial reduction of substituted acetophenones
EP1791965A1 (en) Enantioselective biotransformation for preparation of protein tyrosine kinase inhibitor intermediates
DK2639216T3 (en) Halogenated Indones and Methods for Preparation of Optically Active Indanones or Optically Active Indanols Using These
US20090093627A1 (en) Process for preparing intermediates of ezetimibe by microbial reduction
US7666659B2 (en) Process for producing optically active 3-hydroxypropionic ester derivative
JP4818507B2 (ja) 光学活性3−キヌクリジノールの製造法
JP3703928B2 (ja) 光学活性n−ベンジル−3−ピロリジノールの製造方法
JP4000263B2 (ja) (3r,5s)−(e)−7−[2−シクロプロピル−4−(4−フルオロフェニル)−キノリン−3−イル]−3,5−ジヒドロキシヘプト−6−エン酸エステル類の製造方法
CZ379099A3 (cs) Stereoselektivní mikrobiální redukce racemického tetralonu
WO2007097336A1 (ja) (2r,3r)および(2s,3s)-3-フェニルイソセリン誘導体の製造法
EP0862645B1 (en) Stereoselective microbial reduction process
WO2002000585A1 (en) Chlorohydroxyacetone derivative and process for producing optically active chloropropanediol derivative from the same
JP2000175693A (ja) (r)−2−ヒドロキシ−1−フェノキシプロパン誘導体の製造方法
WO2008022627A2 (de) Verfahren zur herstellung von optisch aktiven hydroxyalkylacetaten durch racematspaltung von 4-hydr0xy-2-ket0nen unter verwendung von baeyer-vi lliger monooxygenasen
JP2004254554A (ja) 光学活性2−メトキシ−1−(4−トリフルオロメチル−フェニル)エタノールの製造方法
JP5474280B2 (ja) 光学活性なtrans体含窒素環状β−ヒドロキシエステルの製造方法
JP3843692B2 (ja) 光学活性endo−ノルボルネオールの製造法
EP1445324A1 (en) Process for producing optically active chroman derivative and intermediate
JP2003235595A (ja) 光学活性ヒドロキシケトエステルの製造法
CN107429270A (zh) 用于制备hcv的大环蛋白酶抑制剂的方法和中间体
JP2003079392A (ja) 光学活性α−トリフルオロメチル乳酸の製造方法
JP2000197496A (ja) 光学活性なα―ヒドロキシラクトン類の製造方法
JP2002281991A (ja) 転移体の副生を抑制した(r)−2−ヒドロキシ−1−フェノキシプロパン誘導体の製造法
JP2004201576A (ja) 光学活性1、3−アルキルジオール−1−ベンジルエーテル誘導体の製造方法

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 21, NO 8, PAGE(S) 910 UNDER THE HEADING APPLICATIONS ACCEPTED - NAME INDEX UNDER THE NAME NISSAN CHEMICAL INDUSTRIES, LTD., APPLICATION NO. 2002228413, UNDER INID (72) CORRECT THE CO INVENTOR NAME TO READ HOSOKAWA, AKEMI.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired